The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Refined estimates of local recurrence risks and the impact of the DCIS score adjusting for clinico-pathological features: Meta-analysis of E5194 and Ontario DCIS cohort studies.
 
Eileen Rakovitch
Research Funding - Genomic Health (Inst)
 
Robert James Gray
Research Funding - Abbott Molecular; Agios; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Genzyme; GlaxoSmithKline; ImClone Systems; Janssen-Ortho; Kanisa; Millennium; Nodality; Novartis; Onyx; OSI Pharmaceuticals; Pfizer; Sanofi; Sequenta; Syndax
 
Frederick L. Baehner
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
 
Dave P. Miller
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
 
Rinku Sutradhar
Research Funding - Genomic Health (Inst)
 
Michael Crager
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Travel, Accommodations, Expenses - Genomic Health
 
Sumei Gu
Research Funding - Genomic Health (Inst)
 
Sharon Nofech-Mozes
Research Funding - Genomic Health
 
Sunil S. Badve
No Relationships to Disclose
 
Wedad Hanna
No Relationships to Disclose
 
Lorie L. Hughes
No Relationships to Disclose
 
William C. Wood
No Relationships to Disclose
 
Lawrence Frank Paszat
No Relationships to Disclose
 
Steven Shak
Employment - Genomic Health
Leadership - Genomic Health
Stock and Other Ownership Interests - Genomic Health
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - AstraZeneca; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst)
 
Lawrence J. Solin
No Relationships to Disclose